Global Viral Inactivation Market Size Study By Method (Solvent Detergent Method, Pasteurization) By Product (Kits and Reagents, Services, Viral Inactivation Systems and Accessories)by Application (Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products, Vaccines and Therapeutics)by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes) and Regional Forecasts 2017-2025

July 2018 | 120 pages | ID: G1379159313EN
Bizwit Research & Consulting LLP

Abstracts

Global Viral Inactivation Market to reach USD 771.3 million by 2025.

Global Viral Inactivation Market valued approximately USD 319.2 million in 2016 is anticipated to grow with a healthy growth rate of more than 14.5% over the forecast period 2017-2025. Global rise in the number of chronic diseases like cancer, diabetes, autoimmune disorders, and other diseases has led to an increase in healthcare expenditure as well as increase in healthcare spending has mainly boosted the market for development of new & enhanced therapies to tackle the rise in these diseases. Increasing R&D innovation, drug discoveries, and FDA approvals leading to commercialization of new drugs has resulted in growth of the market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors&challenges which will define the future growth of the market. Additionally, the report shall also incorporate availableopportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

• By Method
• Solvent Detergent Method
• Pasteurization
• By Product
• Kits and Reagents
• Services
• Viral Inactivation Systems and Accessories
• by Application
• Blood & Blood Products
• Cellular & Gene Therapy Products
• Stem Cell Products
• Tissue & Tissue Products
• Vaccines and Therapeutics
• by End User
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGAA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Viral Inactivation in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL VIRAL INACTIVATION MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL VIRAL INACTIVATION MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL VIRAL INACTIVATION MARKET, BY METHOD

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Viral Inactivation Market, Sub Segment Analysis
  5.3.1. Solvent Detergent Method
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Pasteurization
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL VIRAL INACTIVATION MARKET, BY PRODUCT

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Viral Inactivation Market, Sub Segment Analysis
  6.1.1. Kits and Reagents
    6.1.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.1.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.1.2. Services
    6.1.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.1.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.1.3. Viral Inactivation Systems and Accessories
    6.1.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.1.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL VIRAL INACTIVATION MARKET, BY APPLICATION

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Viral Inactivation Market, Sub Segment Analysis
  7.3.1. Blood and Blood Products
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Cellular and Gene Therapy Products
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.3. Stem Cell Products
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.4. Tissue & Tissue Products
    7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.5. Vaccine and Therapeutics
    7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL VIRAL INACTIVATION MARKET, BY END-USER

8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Viral Inactivation Market, Sub Segment Analysis
  8.3.1. Pharmaceutical & Biotechnology Companies
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Contract Research Organizations
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. Academic Research Institutes
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. GLOBAL VIRAL INACTIVATION MARKET, BY REGIONAL ANALYSIS

9.1. Viral Inactivation Market, Regional Market Snapshot (2015-2025)
9.2. North America Viral Inactivation Market Snapshot
  9.2.1. U.S.
    9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.2.2. Canada
    9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Viral Inactivation Market Snapshot
  9.3.1. U.K.
    9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.2. Germany
    9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.3. France
    9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.4. Rest of Europe
    9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Viral Inactivation Market Snapshot
  9.4.1. China
    9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.2. India
    9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.3. Japan
    9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.4. Rest of Asia Pacific
    9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Rest of The World
  9.5.1. South America
    9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.5.2. Middle East and Africa
    9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.2. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.4. Application Size breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
  10.3.1. Clean Cells (France)
    10.3.1.1. Overview
    10.3.1.2. Financial (Subject to Data Availability)
    10.3.1.3. Product Summary
    10.3.1.4. Recent Developments
  10.3.2. Charles River Laboratories International, Inc. (U.S.)
  10.3.3. Danaher Corporation (U.S.)
  10.3.4. Merck KGAA (Germany
  10.3.5. Parker Hannifin (U.S.)
  10.3.6. Rad Source Technologies (U.S.)
  10.3.7. Sartorius AG (Germany)
  10.3.8. SGS S.A. (Switzerland)
  10.3.9. Texcell, Inc. (France)
  10.3.10. Viral Inactivated Plasma Systems SA (Switzerland)
  10.3.11. WuXi PharmaTech (Cayman) Inc. (China)